跳至主要内容
临床试验/CTRI/2022/09/045719
CTRI/2022/09/045719尚未招募未知

Evaluation of Indocyanine Green for sentinel lymph node biopsy in breast cancer: Two arm, Open label, Parallel design, Non-inferiority, Randomised control trial

Department of Surgical Disciplines0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Upfront operable primary breast cancer measuring upto and including 5cm in maximum tumour dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0) undergoing upfront surgery
  • Consenting patient

排除标准

  • Pregnant or lactating women
  • Patients who have received neo-adjuvant chemotherapy.
  • Patients with history of previous surgery of axilla or chest wall.
  • Patients with history of previous radiotherapy to the breast or axilla.
  • H/o hypersensitivity to any of the agents used.

研究者

发起方
Department of Surgical Disciplines

相似试验